Revision as of 19:13, 1 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit | Revision as of 19:24, 1 September 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_PhaNext edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Watchedfields = changed | |||
| verifiedrevid = 444070509 | | verifiedrevid = 444070509 | ||
| IUPAC_name = 2-propylpyridine-4-carbothioamide | | IUPAC_name = 2-propylpyridine-4-carbothioamide |
Revision as of 19:24, 1 September 2011
Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.034.615 |
Chemical and physical data | |
Formula | C9H12N2S |
Molar mass | 180.271 g/mol g·mol |
(verify) |
Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
It has also been tested for use in the treatment of leprosy.
See also
References
- Wang F, Langley R, Gulten G; et al. (2007). "Mechanism of thioamide drug action against tuberculosis and leprosy". J. Exp. Med. 204 (1): 73–8. doi:10.1084/jem.20062100. PMC 2118422. PMID 17227913.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH (2006). "A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy". Am. J. Trop. Med. Hyg. 74 (3): 457–61. PMID 16525107.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)
Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Nucleic acid inhibitor |
| ||||||||
Protein synthesis inhibitor |
| ||||||||
Cell envelope antibiotic |
| ||||||||
Other/unknown | |||||||||
Combinations | |||||||||
|
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |